期刊文献+

肝功能异常水平对慢性心力衰竭患者的预测价值 被引量:7

Prognostic value of liver function abnormalities in patients with chronic heart failure
下载PDF
导出
摘要 目的探讨慢性心力衰竭(chronic heart failure,CHF)患者肝功能损害水平与CHF严重程度之间的关系。方法87例CHF住院患者根据纽约心功能分级分为心功能Ⅱ级23例,心功能Ⅲ~Ⅳ级64例。CHF患者入院第2天行肝功能、脑钠肽(brain natriuretic peptide,BNP)及超声心动图检查。同期,选取30例排除心力衰竭的门诊体检者行肝功能及超声心动图检查。结果CHF组血清丙氨酸氨基转移酶(Alt)、天门冬氨酸氨基转移酶(Ast)和总胆红素均显著高于对照组,差异有统计学意义(P<0.05)。心功能Ⅲ~Ⅳ级组丙氨酸氨基转移酶、天门冬氨酸氨基转移酶、总胆红素和BNP均显著高于心功能Ⅱ级组,差异有统计学意义(P<0.05)。CHF组白蛋白和左心室射血分数低于对照组,心功能Ⅲ~Ⅳ级组白蛋白和左心室射血分数低于心功能Ⅱ级组,差异均有统计学意义(P<0.05)。心功能Ⅲ~Ⅳ级组直接胆红素水平高于对照组,差异有统计学意义(P<0.05)。CHF组丙氨酸氨基转移酶、天门冬氨酸氨基转移酶、总胆红素、直接胆红素与BNP成正相关(r1=0.37,r2=0.434,r3=0.49,r4=0.406,P<0.01);丙氨酸氨基转移酶、总胆红素和BNP与左心室射血分数成负相关(r1=-0.303,r2=-0.426,r3=-0.455,P<0.01)。结论CHF患者常出现肝功能及BNP水平改变,其水平高低对于判断心力衰竭的严重程度有一定的预测意义。 Objective To investigate the relationship between liver function abnormalities and the severity of heart failure in patients with chronic heart failure (CHF). Methods Totally 87 patients with CHF classified as cardiac functional class II -IV according to New York Heart Association functional classification (23 cases with class II and 64 cases with class III -IV ) were investigated. Ultrasonic cardiogram (UCG), liver function and serum level of brain natriuretic peptide (BNP) were detected the day after admission. UCG and liver function were also examined in 30 cases without CHF (controls). Results Alanine transaminase (Alt), aspartate transaminase (Ast) and total bilirubin (Tbil) levels were significantly increased in patients with CHF as compared with those in the controls (P〈0.05). Ah, Ast, Tbil and BNP levels in patients with class III-IV were obviously higher than those in patients with class II (P〈 0.05 ). Serum level of albumin (Alb) and left ventricular ejection fraction(LVEF) in patients with CHF were lower than those in controls, and those in patients with class Ill-iV were lower than those in patients with class II (P〈0.05). Serum level of direct bilirubin (Dbil) in patients with class HI-IV was higher than that in controls (P〈0.05). Levels of Alt, Ast and Tbil were positively correlated with serum BNP levels (r1=0.37, r2=0.434, r3=0.49, r4=0.406, P〈0.O1 ) in patients with CHF. Moreover, levels of Ah, Tbil and BNP were negatively correlated with LVEF (r1=-0.303 ,r2=- 0.426, r3=-0.455, P〈0.01 ). Conclusion Liver function abnormalities and BNP change are common in patients with CHF. Liver function abnormalities and BNP levels may be useful for predicting the severity of heart failure in patients with CHF.
出处 《岭南心血管病杂志》 2013年第2期178-181,共4页 South China Journal of Cardiovascular Diseases
关键词 心力衰竭 充血性 肝功能异常 脑钠肽 heart failure, congestive liver function abnormality brain natriuretic peptide
  • 相关文献

参考文献10

  • 1DAMMAN K, NAVIS G, VOORS A A, et al. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis[J]. J Card Fail, 2007, 13(8) :599-608.
  • 2FELKER G M, ALLEN L A, POCOCK S J, et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank [J]. J Am Coll Cardiol, 2007, 50 ( 1 ) : 40-47.
  • 3GIALLOURAKIS C C, ROSENBERG P M, FRIEDMAN L S. The liver in heart failure [ J ]. Clin Liver Dis, 2002,6 (4) : 947- 967, viii-ix.
  • 4FAGGIANO P, VALLE R, ASPROMONTE N, et al. How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve Short- term prognostic stratification [J]. Int J Cardiol, 2010, 140 ( 1 ) : 88-94.
  • 5VAN DEURSEN V M, DAMMAN K, HILLEGE H L, et al. Abnormal liver function in relation to hemodynamic profile in heart failure patients[J]. J Card Fail, 2010, 16( 1 ) : 84-90.
  • 6AMBROSY A P, VADUGANATHAN M, HUFFMAN M D, et al. Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial[J]. Eur Heart Fail. 2012. 14(3) :302-311.
  • 7于胜波,崔红营,秦牧,刘韬,孔彬,赵庆彦,黄鹤,黄从新.肝功能异常对慢性收缩性心力衰竭患者预后的影响[J].中华医学杂志,2011,91(38):2673-2677. 被引量:20
  • 8程友琴,曹少军,尹秋生,崔吉君.老年心力衰竭患者血胆红素水平的变化[J].中华老年医学杂志,2001,20(5):331-333. 被引量:10
  • 9SHINAGAWA H, INOMATA T, KOITABASHI T, et al. Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure[J]. Circ J, 2008, 72(3): 364-369.
  • 10ALLEN LA, FELKER GM, POCOCK S, et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program [J]. Eur J Heart Fail, 2009, 11(2) : 170-177.

二级参考文献16

  • 1侯凡凡,马志刚,梅长林,戎殳,黄颂敏,刘先蓉,袁伟杰,郭云珊,王莉,何强,王秀玲,桑晓红,栗霄立.我国五省市、自治区慢性肾脏病患者心血管疾病的危险因素调查[J].中华医学杂志,2005,85(11):753-759. 被引量:25
  • 2Dickstein K,Cohen-Solal A,Filippatos G,et al.ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008:the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).Eur J Heart Fail,2008,10:933-989.
  • 3Schaufelberger M,Swedberg K,K(ó)ter M,et al.Decreasing oneyear mortality and hospitalization rates for heart failure in Sweden ;Data from the Swedish Hospital Diacharge Registry 1988 to 2000.Eur Heart J,2004,25:300-307.
  • 4Levy D,Kenchaiah S,Lardon MG,et al.Long-term trends in the incidence of and survival with heart failure.N Engl J Med,2002,347:1397-1402.
  • 5Allen LA,Felker GM,Pocock S,et al.Liver function abnormalities and outcome in patients with chronic heart failure:data from the Candesartan in Heart Failure:Assessment of Reduction in Mortality and Morbidity (CHARM) program.Eur J Heart Fail,2009,11:170-177.
  • 6Batin P,Wickens M,McEntegart D,et al.The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure.Eur Heart J,1995,16:1613-1618.
  • 7Reinhartz O,Farrar DJ,Hershon JH,et al.Importance of preoperative liver function as a predictor of survival in patients supported with Thoratec ventricular assist devices as a bridge totransplantation.J Thorac Cardiovasc Surg,1998,116:633-640.
  • 8Shinagawa H,Inomata T,Koitabashi T,et al.Prognosticsigniticance of increased serum bilirubin levels coincident with cardiac decompeasation in chronic heart failure.Circ J,2008,72:364-369.
  • 9Lau GT,Tan HC,Kritharides L.Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation.Am J Cardiol,2002,90:1405-1409.
  • 10van Deursen VM,Damman K,Hillege HL,et al.Abnormal liver function in relation to hemodynamic profile in heart failure patients.J Card Fail,2010,16:84-90.

共引文献27

同被引文献61

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部